Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-28
2008-09-16
Saeed, Kamal (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S209000, C546S210000, C548S200000, C548S215000, C548S314700, C548S518000
Reexamination Certificate
active
07425633
ABSTRACT:
A compound of the following formula:wherein R1, R2, R3, R4, R5, R6, R7, R8, T, X, Y, and Z are as defined herein. Also disclosed is a method for inhibiting dipeptidyl peptidase IV or for treating Type II diabetes with such a compound.
REFERENCES:
patent: WO 2004/016587 (2004-02-01), None
patent: WO 2005/007316 (2005-08-01), None
Type 2 diabetes [online], [retrieved on Oct. 26, 2007]. Retrieved from the Internet, URL; http://www.mayoclinic.com/health/type-2-diabetes/DS00585>.
Diabetes mellitus type 2 [online], [retrieved on Oct. 26, 2007]. Retrieved from the Internet, URL; http://en.wikipedia.org/wiki/Diabetes—mellitus—type—2>.
CAPLUS, retrieved on May 13, 2008, Accession No. 2005:729632, Document No. 143:194237.
Chao Yu-Sheng
Hsieh Hsing-Pang
Jiaang Weir-Torn
National Health Research Institutes
Occhiuti Rohlicek & Tsao LLP
Saeed Kamal
Young Shawquia
LandOfFree
Pyrrolidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolidine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3979140